Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
Highlighted publications
←
→
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
Maternal & child health
Serum Amino Acid Profiles in Childhood Predict Triglyceride Level in Adulthood: A 7-Year Longitudinal Study in Girls
P. Wiklund et. al, The Journal of Clinical Endocrinology & Metabolism, 2016
Inflammation & immunity
Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses
V. Aho et. al, Scientific Reports, 2016
T. Roman et. al, The American Journal of Human Genetics, 2015
A. Cichonska et. al, Bioinformatics, 2016
Medicines & trials, Genetics
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
P. Würtz et. al, Journal of the American College of Cardiology, 2016
F. Drenos et. al, Circulation: Cardiovascular Genetics, 2016
Liver disease
Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study
J. Kaikkonen et. al, Free Radical Research, 2015
P. Wiklund et. al, Scientific Reports, 2016
J. Kettunen et. al, Nature Communications, 2016
Genetics, Diabetes
Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
L. Lotta et. al, PLOS Medicine, 2016
Liver disease, Genetics
Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism—The Young Finns Study
E. Raitoharju et. al, Scientific Reports, 2016
Obesity & bodyweight
Abdominal obesity and circulating metabolites: A twin study approach
L. Bogl et. al, Metabolism, 2015
Cardiovascular disease
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
L. Engelbrechtsen et. al, Obesity Science & Practice, 2017
M. Cannon et. al, G3 Genes|Genomes|Genetics, 2017
Cardiovascular disease, Diabetes
The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis
I. Seppälä et. al, Scientific Reports, 2017